Literature DB >> 26443484

Reduced occurrence of ventilator-associated pneumonia after cardiac surgery using preoperative 0.2% chlorhexidine oral rinse: results from a single-centre single-blinded randomized trial.

Y J Lin1, L Xu2, X Z Huang2, F Jiang2, S L Li2, F Lin2, Q Y Ye2, M L Chen2, J L Lin2.   

Abstract

Since mechanical ventilation after cardiac surgery increases the risk of ventilator-associated pneumonia (VAP), we conducted a prospective randomized controlled trial to investigate the effect of preoperative 0.2% chlorhexidine on postoperative VAP. Ninety-four patients scheduled for heart surgery were randomized to a chlorhexidine group (N = 47) or control (saline) group (N = 47). On the day before surgery, patients gargled three times with 0.2% chlorhexidine or saline 30 min after each meal and 5 min after teeth brushing at bedtime. VAP occurred in 8.5% of the chlorhexidine group and in 23.4% of the controls. Preoperative chlorhexidine mouthwash reduced the incidence of postoperative VAP significantly.
Copyright © 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac surgery; Chlorhexidine; Prophylaxis; Ventilator-associated pneumonia

Mesh:

Substances:

Year:  2015        PMID: 26443484     DOI: 10.1016/j.jhin.2015.08.018

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  2 in total

1.  The Two-Component System ChtRS Contributes to Chlorhexidine Tolerance in Enterococcus faecium.

Authors:  Ana M Guzmán Prieto; Jessica Wijngaarden; Johanna C Braat; Malbert R C Rogers; Eline Majoor; Ellen C Brouwer; Xinglin Zhang; Jumamurat R Bayjanov; Marc J M Bonten; Rob J L Willems; Willem van Schaik
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Evaluating the Efficacy of Nanosil Mouthwash on the Preventing Pulmonary Infection in Intensive Care Unit: a Randomized Clinical Trial.

Authors:  Bahareh Khaky; Ahmadreza Yazdannik; Hosein Mahjobipoor
Journal:  Med Arch       Date:  2018-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.